United States · FDA National Drug Code directory
Clozapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-5419_1b735bc2-6341-40af-8696-e61621d91ee8
- Product NDC
- 0093-5419
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Clozapine
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170725
- Source listing expiry
- 20261231
Source-listed ingredients
- CLOZAPINE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-5419-01) · 0093-5419-01
- 48 BLISTER PACK in 1 CARTON (0093-5419-84) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5419-19) · 0093-5419-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →